BSAC Spring Conference 2020

Into Clinical Practice
- Bridging the gap between science, policy and effective antimicrobial use

CANCELLED

16-17 March 2020

Queen Elizabeth Conference Centre, Westminster, London

Dr Philippe Villain Guillot

CEO, Nosopharm

Philippe Villain-Guillot has been Nosopharm’s chief executive officer since co-founding the company in 2009. In this first entrepreneurial venture, he grew the company to include a staff of 8 high-skilled employees and established a robust IP portfolio. Since the inception of the company, Philippe has raised €4.3 million in private equity and €3.4 million in public grants. Prior to co-founding Nosopharm, Philippe gained experience in medicinal chemistry at Evotec (UK) and focused on natural products at CIATEJ (Mexico). Philippe holds a PhD in medicinal chemistry from the University of Montpellier.

Top